Is there a way for cost reduction in fluid therapy without a loss in quality;Ist eine kostenreduktion in der flussigkeitstherapie bei wahrung der qualitat in der intensivtherapie moglich?

Anaesthesist

Volumn 47, Issue 5, 1998, Pages 395-399

  Prien, Th ^a   Singbartl, K ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Colloids; Cost reduction; Cystalloids; Fluid therapy

Indexed keywords

ALBUMIN; RINGER LACTATE SOLUTION; SODIUM CHLORIDE;

ANAPHYLAXIS; ARTICLE; BLOOD CLOTTING DISORDER; COLLOID; COST CONTROL; CRYSTALLOID; DRUG COST; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG QUALITY; FLUID THERAPY; HUMAN; HYGIENE;

CHEMISTRY, PHARMACEUTICAL; COST CONTROL; HUMANS; INFUSIONS, INTRAVENOUS; INTENSIVE CARE; QUALITY CONTROL;

EID: 0031859106     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001010050575     Document Type: Article

References (11)

1. Durand-Zaleski I, Bonnet F, Rochant H, Bierling P, Lemaire F (1992) Usefulness of consensus conferences: the case of albumin. Lancet 340:1388-1390
2. Emerson TE (1989) Unique features of albumin: a brief review. Crit Care Med 17:690-693
3. Golub R, Sorrento JJ, Cantu R, Nierman DM, Moideen A, Stein DH (1994) Efficacy of albumin supplementation in the surgical intensive care unit: A prospective, randomized study. Crit Care Med 22:613-619
4. Jantzen JP, Piek J (1997) Leitlinien zur Primärversorgung von Patienten mit Schädel-Hirn-Trauma. Anästh Intensivmed 38:89-93
5. Laxenaire MC, Charpentier C, Feldman L (1994) Réactions anaphylactoïdes aux substituts colloïdaux du plasma: incidence, facteurs de risque, mécanismes. Ann Fr Anesth Réanim 13:301-310
6. Lundsgaard-Hansen P, Tschirren B (1981) Clinical experience with 120,00 units of modified fluid gelatin. In: Joint WHO/IABS Symposium on the standardization of albumin, plasma substitutes and plasmapheresis. Dev Biol Stand 48:251-256
7. Prien Th, Backhaus N, Pelster F, Pircher W, Bünte H, Lawin P (1990) Effect of intraoperative fluid administration and colloid osmotic pressure on the formation of intestinal edema during gastrointestinal surgery. J Clin Anesth 2:317-323
8. Ring J, Messmer K (1977) Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1:466-469
9. Schrieber R, Seybold U (1993) Gelatine production, the six steps to maximum safety. In: Brown F (ed) Transmissible spongiform encephalopathies - impact on animal and human health. Dev Biol Stand 80:195-198
10. Vermeulen LC, Ratko TA, Erstad B, Brecher ME, Matuszewski KA (1995) A paradigm for consensus - The university hospital consortium guidelines for the use of albumin, nonprotein colloid, and cristalloid solutions. Arch Int Med 155:373-379
11. WHO Press release vom 3. April 1996: International experts propose measures to limit spread of BSE and reduce possible human risks from disease